An Experimental Vaccine May Lengthen the Lives of Prostate Cancer Patients
May 1, 2009
Seattle-based Dendreon Corp. says its experimental Provenge cancer vaccine can lengthen the lives of men with advanced prostate cancer.
Topics:
Health Medical Pharma, Dendreon, Urology, Medicine, Sipuleucel-T, Prostate, Prostate cancer, Cancer vaccine, Cancer treatments, Cancer, experimental Provenge cancer, Dendreon Corp., advanced prostate cancer, Seattle
